Denelle Waynick
Director/Board Member at RA PHARMACEUTICALS, INC.
Denelle Waynick active positions
| Companies | Position | Start | End |
|---|---|---|---|
| RA PHARMACEUTICALS, INC. | Director/Board Member | 01/04/2020 | - |
| UCB | General Counsel | 31/03/2023 | - |
| Atlanta Volunteer Lawyers Foundation, Inc. | Director/Board Member | - | - |
Career history of Denelle Waynick
Former positions of Denelle Waynick
| Companies | Position | Start | End |
|---|---|---|---|
| ZOGENIX, INC. | Director/Board Member | 20/09/2020 | 06/03/2022 |
| Independent Dir/Board Member | 20/09/2020 | 06/03/2022 | |
| MYOKARDIA, INC. | General Counsel | 05/07/2020 | 16/11/2020 |
| Corporate Secretary | 05/07/2020 | 16/11/2020 | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | General Counsel | - | - |
| ABBVIE INC. | General Counsel | - | - |
| University of California, Berkeley | General Counsel | - | - |
| SANA AB | General Counsel | 31/12/2020 | - |
Training of Denelle Waynick
| Howard University School of Law | Graduate Degree |
| Rutgers University- Newark | Undergraduate Degree |
Statistics
International
| United States | 10 |
| Denmark | 2 |
| Belgium | 2 |
Operational
| General Counsel | 6 |
| Director/Board Member | 3 |
| Corporate Secretary | 1 |
Sectoral
| Health Technology | 8 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| SANA AB | Health Technology |
| ABBVIE INC. | Health Technology |
| UCB | Health Technology |
| Private companies | 5 |
|---|---|
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
| Atlanta Volunteer Lawyers Foundation, Inc. |
- Stock Market
- Insiders
- Denelle Waynick
- Experience